Fluor Awarded More Than $1 Billion in Life Sciences Contracts

Fluor Corporation (NYSE: FLR) announced today that it has been awarded a $487 million biotech expansion project in Denmark and is also mobilizing resources in the central U.S. for the first phase of a new life sciences production facility valued at $574 million.Read more at Business Wire.